Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P47897: Variant p.Tyr57His

Glutamine--tRNA ligase
Gene: QARS1
Feedback?
Variant information Variant position: help 57 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Tyrosine (Y) to Histidine (H) at position 57 (Y57H, p.Tyr57His). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and aromatic (Y) to medium size and polar (H) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In MSCCA; results in reduced glutaminyl-tRNA aminoacylation activity; does not affect interaction with RARS1. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 57 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 775 The length of the canonical sequence.
Location on the sequence: help ATQAQQTLGSTIDKATGILL Y GLASRLRDTRRLSFLVSYIA The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 2 – 775 Glutamine--tRNA ligase
Modified residue 70 – 70 Phosphoserine
Helix 50 – 62



Literature citations
Mutations in QARS, encoding glutaminyl-tRNA synthetase, cause progressive microcephaly, cerebral-cerebellar atrophy, and intractable seizures.
Zhang X.; Ling J.; Barcia G.; Jing L.; Wu J.; Barry B.J.; Mochida G.H.; Hill R.S.; Weimer J.M.; Stein Q.; Poduri A.; Partlow J.N.; Ville D.; Dulac O.; Yu T.W.; Lam A.T.; Servattalab S.; Rodriguez J.; Boddaert N.; Munnich A.; Colleaux L.; Zon L.I.; Soll D.; Walsh C.A.; Nabbout R.;
Am. J. Hum. Genet. 94:547-558(2014)
Cited for: FUNCTION; TISSUE SPECIFICITY; SUBCELLULAR LOCATION; INTERACTION WITH RARS1; VARIANTS MSCCA VAL-45; HIS-57; TRP-403 AND TRP-515; CHARACTERIZATION OF VARIANTS MSCCA VAL-45; HIS-57; TRP-403 AND TRP-515; The crystal structure of human GlnRS provides basis for the development of neurological disorders.
Ognjenovic J.; Wu J.; Matthies D.; Baxa U.; Subramaniam S.; Ling J.; Simonovic M.;
Nucleic Acids Res. 44:3420-3431(2016)
Cited for: X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF WILD-TYPE AND VARIANTS MSCCA VAL-45 AND HIS-57; FUNCTION; CATALYTIC ACTIVITY; SUBUNIT; MUTAGENESIS OF HIS-175; CHARACTERIZATION OF VARIANTS MSCCA VAL-45; HIS-57; TRP-403 AND TRP-515;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.